CN104351771A - 甜茶抗过敏食品及其制备方法 - Google Patents
甜茶抗过敏食品及其制备方法 Download PDFInfo
- Publication number
- CN104351771A CN104351771A CN201410572649.0A CN201410572649A CN104351771A CN 104351771 A CN104351771 A CN 104351771A CN 201410572649 A CN201410572649 A CN 201410572649A CN 104351771 A CN104351771 A CN 104351771A
- Authority
- CN
- China
- Prior art keywords
- sweet tea
- honeysuckle
- purple perilla
- radix glycyrrhizae
- antiallergic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 50
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 22
- 235000013305 food Nutrition 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241001122767 Theaceae Species 0.000 title claims description 41
- 235000004347 Perilla Nutrition 0.000 claims abstract description 35
- 241000229722 Perilla <angiosperm> Species 0.000 claims abstract description 35
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 31
- 239000000284 extract Substances 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 12
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 11
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000811 xylitol Substances 0.000 claims abstract description 11
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 11
- 229960002675 xylitol Drugs 0.000 claims abstract description 11
- 235000010447 xylitol Nutrition 0.000 claims abstract description 11
- 239000004375 Dextrin Substances 0.000 claims abstract description 10
- 229920001353 Dextrin Polymers 0.000 claims abstract description 10
- 235000019425 dextrin Nutrition 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 5
- 244000281702 Dioscorea villosa Species 0.000 claims description 9
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 6
- 230000007246 mechanism Effects 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 8
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 4
- 235000011477 liquorice Nutrition 0.000 abstract 4
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 description 10
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 230000007815 allergy Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012434 Dermatitis allergic Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明的甜茶抗过敏食品，由下列重量份的物料制成：紫苏甘草金银花甜茶提取物：5～20，糊精：15～30，淮山粉：15～30，木糖醇：15～30。所述紫苏甘草金银花甜茶混合提取物为紫苏/甘草/金银花/甜茶＝5～15/10～20/1～3/10～20混合物的提取物。本发明还提供上述所述的甜茶抗过敏食品的制备方法。本发明中，紫苏、甘草、金银花、甜茶均有抗过敏的作用，特别是各成份从不同的角度和机理上发挥作用，在抗过敏作用方面互相协同，在克服各组分的缺点方面互相抵消，效果好副作用少，是一种有效的符合科学、合理、健康理念的抗过敏食品。本发明还涉及甜茶抗过敏食品的制备方法。
Description
技术领域
本发明涉及抗过敏食品，具体是甜茶抗过敏食品及其制备方法。
背景技术
过敏反应又称超敏反应或***反应，是指机体受同一抗原物质再次刺激后产生的一种异常或病理性免疫反应。过敏性疾病的发病率大约占人口的20％，从新生儿到中老年人各年龄段都有可能发生。
最常见的过敏为空气过敏、食物过敏、花粉过敏。现代医学治疗过敏可采用对症缓解治疗，脱敏治疗等办法，可其存在副作用大，治疗时间长，费用高，需长期到医院定点治疗等弊端。
发明内容
为使人们更加方便的治疗和预防过敏，克服现有技术的不足，本发明提供一种甜茶抗过敏食品。
本发明的甜茶抗过敏食品，由下列重量份的物料制成：紫苏甘草金银花甜茶提取物：5～20，糊精：15～30，淮山粉：15～30，木糖醇：15～30。
所述紫苏甘草金银花甜茶混合提取物为紫苏/甘草/金银花/甜茶＝5～15/10～20/1～3/10～20混合物的提取物。
作为优选，各物料的重量份为：紫苏甘草金银花甜茶混合提取物：10～15，糊精：20～25，淮山粉：20～25，木糖醇：20～25。
进一步，所述紫苏甘草金银花甜茶混合提取物为紫苏/甘草/金银花/甜茶＝5～15/10～20/1～3/10～20混合物的50～80％乙醇水溶液提取物。
更进一步，所述紫苏甘草金银花甜茶混合提取物为紫苏/甘草/金银花/甜茶＝10/15/3/15混合物的50～80％乙醇水溶液提取物。
本发明还提供上述所述的甜茶抗过敏食品的制备方法。
该方法包含下述步骤：
(1)将紫苏、甘草、金银花、甜茶粉碎后一起放入提取罐中；
(2)使用50～80％乙醇水溶液提取；
(3)提取液浓缩干燥；
(4)将(3)所得与糊精、淮山粉、木糖醇混合、制粒；
(5)干燥；
(6)内分装和外包装。
进一步，在步骤(2)，加热至不超过60度，提取2～3次，每次时间为1～3小时。
在步骤(2)使用70％乙醇水溶液。
在步骤(3)和(5)，温度不超过60度，真空干燥。
在步骤(4)，制粒粒径为0.1～2mm。
在步骤(5)，干燥至产品含水0.1～5％。
中医认为，紫苏味辛，性温，入脾、肺经，具有解表散寒、行气宽中、解鱼蟹毒之功效。紫苏提取物HD、HC能显著抑制透明质酸酶活性，显著拮抗组织胺所致的皮肤毛细血管通透性增加，体现出较强的抗炎抗过敏作用，有缓和过敏性皮炎、花粉症等过敏反应的效果。紫苏对吃海鲜出现的瘙痒、风团、丘疹、腹痛等过敏反应有奇效。
另外紫苏含有丰富的维生素C、钾、铁等，还含有丰富的不饱和脂肪酸。常饮用紫苏泡水能起到预防海鲜过敏，缓解皮肤过敏症状，补充维生素以及矿物质的作用，对身体无副作用。
中医素有“十方九甘草”之说，现代药理研究证实甘草主要含甘草甜素，其水解产物——甘草次酸的化学结构有类似肾上腺皮质激素的作用，有抗炎、抗毒素、抗过敏作用，并能抑制组织胺的释放。故其对过敏性紫癜、急性湿疹、过敏性皮炎及其它各种皮肤炎症的红肿、糜烂、流水症状都有良好的治疗效果。另外甘草还具有平喘、镇咳的作用，故其在过敏性支气管哮喘的治疗上被广泛应用。另有报道，甘草能治愈过敏性鼻炎。长期使用，对身体并无副作用。
中药金银花是传统的清热解毒药，具有杀菌，抑制病毒等多种药理活性，有报道证明金银花具有治疗食物引起的过敏症的作用。
甜茶提取物对浓氨水实验性咳嗽有抑制作用，能明显增加呼吸道酚红排出量，显示止咳祛痰效果，并具有较好的镇痛，抗炎，镇静作用。在日本，甜茶已用作抗敏药。甜茶提取物具有较强的抗过敏作用。甜茶中所含的黄酮物质可分解黑色素、抑制黑斑和黄褐斑的形成。甜茶是一种无毒、高甜度、低热能和具有保健功能的天然甜味植物，是一种理想的糖类替代品，对避免因长期过量的吃糖、致使人体发胖和诱发高血压、糖尿病、心血管病、肾脏等疾病的人们具有良好辅助疗效。
木糖醇为人体提供能量，合成糖元，减少脂肪和肝组织中的蛋白质的消耗。
淮山富含18种氨基酸和10余种微量元素，及其它矿物质，有健脾胃、补肺肾、补中益气、健脾补虚，固肾益精、益心安神、生津止渴、保健养颜等作用。
本发明中，紫苏、甘草、金银花、甜茶均有抗过敏的作用，特别是各成份从不同的角度和机理上发挥作用，如紫苏通过抑制透明质酸酶活性，拮抗组织胺来缓解皮肤出现的红、肿、热、痛；甘草所含的甘草甜素，其水解产物——甘草次酸具有类似于肾上腺素皮质激素的作用，在炎症早期可减轻渗出、水肿、毛细血管扩张、白细胞浸润及吞噬反应，从而改善红、肿、热、痛等症状，在后期可抑制毛细血管和纤维母细胞的增生，延缓肉芽组织生成，防止糖连及瘢痕形成，减轻后遗症；金银花具有治疗食物引起的过敏症的作用；甜茶具有抗组胺作用，能有效减轻过敏症状。
另外，本发明的技术方案配料合理。甜茶素甜度极高，可以掩盖金银花的苦味，提高了人们对产品的接受程度；紫苏气清香，味微辛，甘草有特殊甜味，都在一定程度上提升了产品的口感；甜茶中的茶多酚作为优良的抗氧化剂，可以有效防止紫苏、甘草、金银花等的有效成分在生产和储存过程中的氧化变质，这正是将紫苏、甘草、金银花、甜茶混合提取的关键。
具体实施方式
(1)将紫苏、甘草、金银花、甜茶破碎后一起放入提取罐中；
(2)使用70％乙醇水溶液提取；提取温度55度，提取3次，每次时间为1小时。合并提取液。
(3)将提取液在温度60度时真空浓缩、真空干燥；
(4)将(3)所得与糊精、淮山粉、木糖醇混合、制粒；制粒粒径为1mm。
(5)真空干燥；检查水分，不得超过5％。
(6)内分装和外包装。
其中，糊精、淮山粉、木糖醇外购；紫苏/甘草/金银花/甜茶的重量比为10/15/3/15；紫苏甘草金银花甜茶混合提取物：10，糊精：20，淮山粉：20，木糖醇：20，均为重量份。
Claims (10)
1.甜茶抗过敏食品，由下列重量份的物料制成：紫苏甘草金银花甜茶提取物：5～20，糊精：15～30，淮山粉：15～30，木糖醇：15～30；
所述紫苏甘草金银花甜茶混合提取物为紫苏/甘草/金银花/甜茶＝5～15/10～20/1～3/10～20混合物的提取物。
2.根据权利要求1所述的甜茶抗过敏食品，其特征在于：物料的重量份为：紫苏甘草金银花甜茶混合提取物：10～15，糊精：20～25，淮山粉：20～25，木糖醇：20～25。
3.根据权利要求1或2所述的甜茶抗过敏食品，其特征在于：所述紫苏甘草金银花甜茶混合提取物为紫苏/甘草/金银花/甜茶＝5～15/10～20/1～3/10～20混合物的50～80％乙醇水溶液提取物。
4.根据权利要求3所述的甜茶抗过敏食品，其特征在于：所述紫苏甘草金银花甜茶混合提取物为紫苏/甘草/金银花/甜茶＝10/15/3/15混合物的50～80％乙醇水溶液提取物。
5.权利要求1或2所述的甜茶抗过敏食品的制备方法，包含下述步骤：
(1)将紫苏、甘草、金银花、甜茶粉碎后一起放入提取罐中；
(2)使用50～80％乙醇水溶液提取；
(3)提取液浓缩干燥；
(4)将(3)所得与糊精、淮山粉、木糖醇混合、制粒；
(5)干燥；
(6)内分装和外包装。
6.根据权利要求5的制备方法，其特征在于：在步骤(2)，加热至不超过60度，提取2～3次，每次时间为1～3小时。
7.根据权利要求5的制备方法，其特征在于：在步骤(2)使用70％乙醇水溶液。
8.根据权利要求5的制备方法，其特征在于：在步骤(3)和(5)，温度不超过60度，真空干燥。
9.根据权利要求5的制备方法，其特征在于：在步骤(4)，制粒粒径为0.1～2mm。
10.根据权利要求5的制备方法，其特征在于：在步骤(5)，干燥至产品含水0.1～5％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410572649.0A CN104351771A (zh) | 2014-10-24 | 2014-10-24 | 甜茶抗过敏食品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410572649.0A CN104351771A (zh) | 2014-10-24 | 2014-10-24 | 甜茶抗过敏食品及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104351771A true CN104351771A (zh) | 2015-02-18 |
Family
ID=52519162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410572649.0A Pending CN104351771A (zh) | 2014-10-24 | 2014-10-24 | 甜茶抗过敏食品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104351771A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1606987A (zh) * | 2003-10-13 | 2005-04-20 | 财团法人工业技术研究院 | 抗过敏组成物 |
| JP2011178679A (ja) * | 2010-02-26 | 2011-09-15 | Kitasato Institute | 和漢生薬由来多糖体を有効成分とする免疫調節剤及び飲食品 |
| CN102949554A (zh) * | 2012-11-06 | 2013-03-06 | 合肥海大生物医药科技有限公司 | 一种治疗过敏性紫癜的中药组合物及其制备方法 |
| CN102961532A (zh) * | 2012-12-10 | 2013-03-13 | 孙振玲 | 一种治疗过敏性紫癜的中药 |
-
2014
- 2014-10-24 CN CN201410572649.0A patent/CN104351771A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1606987A (zh) * | 2003-10-13 | 2005-04-20 | 财团法人工业技术研究院 | 抗过敏组成物 |
| JP2011178679A (ja) * | 2010-02-26 | 2011-09-15 | Kitasato Institute | 和漢生薬由来多糖体を有効成分とする免疫調節剤及び飲食品 |
| CN102949554A (zh) * | 2012-11-06 | 2013-03-06 | 合肥海大生物医药科技有限公司 | 一种治疗过敏性紫癜的中药组合物及其制备方法 |
| CN102961532A (zh) * | 2012-12-10 | 2013-03-13 | 孙振玲 | 一种治疗过敏性紫癜的中药 |
Non-Patent Citations (1)
| Title |
|---|
| 藤建文 等: "广西甜茶多酚的抗过敏性评价", 《食品与机械》, vol. 24, no. 5, 30 September 2008 (2008-09-30), pages 48 - 51 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102204612B (zh) | 包括活性紫杉的中药组合物及其制备方法 | |
| CN107362213B (zh) | 一种具有通便功能的组合物及其制备方法 | |
| CN101543248B (zh) | 一种特别适合“三高一酸”人群饮用的凉茶及其制备方法 | |
| CN104351450A (zh) | 一种橘红润喉奶糖及其制备方法 | |
| CN104381557A (zh) | 一种牛大力糖果制作方法 | |
| CN103747779A (zh) | 毛发促生剂及其制作方法 | |
| CN102845574A (zh) | 一种端午茶及其制作方法 | |
| CN104524146A (zh) | 一种预防和辅助治疗“三高症”中药组合物及其应用 | |
| CN104547515A (zh) | 一种橘红梨膏及其制备方法 | |
| CN105266149A (zh) | 一种铁皮石斛复方保健胶囊及其制备方法 | |
| CN104940759A (zh) | 一种治疗风寒、咳嗽的药膏贴 | |
| CN110652552A (zh) | 一种伤口愈合配方及制备方法 | |
| CN104095269B (zh) | 一种纯天然接骨木籽果饮的制备 | |
| CN105285288A (zh) | 一种辅助治疗咽喉炎的奶糖及其制备方法 | |
| CN108686058A (zh) | 七窍通鼻炎喷剂及其制备方法 | |
| CN104383232B (zh) | 清热解毒苦丁茶含片及其生产方法 | |
| CN104288736A (zh) | 一种紫菀止咳糖果 | |
| CN108057115A (zh) | 一种治疗上呼吸道炎症感染的组合物及其制备方法 | |
| CN104351771A (zh) | 甜茶抗过敏食品及其制备方法 | |
| CN102657782B (zh) | 一种预防上呼吸道感染药茶的制备方法 | |
| CN113018398A (zh) | 一种抗疲劳保健品及其制备方法 | |
| KR20200061285A (ko) | 가랑갈 추출물을 포함하는 혈액순환 및 혈관질환 예방용 식품 조성물 | |
| CN104399049A (zh) | 一种治疗寒性哮喘的中药混合物 | |
| CN116459314B (zh) | 一种延缓衰老喷剂 | |
| CN105687779A (zh) | 一种止咳喘颗粒及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150218 |